| Brand Name | Tagrisso |
| Packaging Type | Strip |
| Molecule | Osimertinib |
| Generic Name | Osimertinib 40mg |
| Manufactured By | Astrazeneca Pharma India |
| Quantity | 10 Tablets |
| Form | Tablets |
| Country of Origin | India |
| Categories | Oncology |
.
Tagrisso targets non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Follow your doctor’s instructions regarding any restrictions on food, beverages, or activities. In particular, avoid grapefruit and grapefruit juice, as they can interfere with how Osimertinib works.
No, Osimertinib is not a traditional chemotherapy drug. It is a targeted therapy that specifically inhibits EGFR mutations involved in the growth and spread of non-small cell lung cancer (NSCLC).
Tagrisso is available in 40 mg and 80 mg doses. The appropriate dose depends on the patient's condition and is determined by the healthcare provider.
Tagrisso has a half-life of approximately 48 hours, meaning it stays in the body for several days after the last dose.
Tagrisso is expensive due to the high cost of research, development, clinical trials, and the complex manufacturing processes involved in producing targeted therapies like Osimertinib.
Some side effects of Tagrisso may subside as your body adjusts to the medication, while others may persist. It's important to consult your healthcare provider for guidance on managing side effects.
The effectiveness of Tagrisso is monitored through regular scans, imaging tests, and assessments of cancer markers by your healthcare provider. Improvement in symptoms may also indicate that the medication is working.
The duration of Tagrisso treatment depends on how well the medication works and how well it is tolerated. Some patients take it for several months or years as long as it remains effective.
No, Tagrisso is neither chemotherapy nor immunotherapy. It is a targeted therapy specifically designed to inhibit mutated EGFR in certain types of lung cancer.
Tagrisso can remain effective for several months or even years, depending on the patient’s response and the progression of their cancer.
Tagrisso is not a cure for lung cancer, but it can significantly extend survival and delay disease progression in patients with advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
You can order Osimertinib by logging into your account on our website, adding the tablet to your cart, and proceeding to checkout. After successful payment, your order will be confirmed, and you will receive a confirmation email. You can also contact us via WhatsApp to place your order directly.
Yes, Tagrisso can interact with several drugs, including antiarrhythmics, antipsychotics, antibiotics, and supplements like St. John’s wort. These interactions may increase the risk of side effects or make Tagrisso less effective.
Yes, Tagrisso may reduce fertility in both males and females. If you're concerned about future fertility, talk to your doctor about options like sperm or egg preservation.
No, Tagrisso is not safe during pregnancy or breastfeeding. Use birth control while taking Tagrisso and for several weeks after your last dose.
